FDA Approval of Carotid Artery Stenting
By Takao Ohki, MD, PhD, Chief Medical Editor
In the near future, simulation training will have a significant impact on the way we learn to execute new procedures.
By James A.M. Smith, DO, and David H. Deaton, MD
These new applications using the Conquest PTA Balloon Dilatation Catheter can preserve vascular access in hemodialysis patients.
By John R. Ross, MD, A-V Access Section Editor
This prospective, randomized trial demonstrates the superiority of iodixanol to low-osmolar contrast media in preventing contrast-induced nephropathy.
By Adam Brodsky, MD, and Charles J. Davidson, MD
By Jason S. Carlson, RT, and Bruce H. Gray, DO
If the results of clinical trials support the more widespread use of PFO closure, the national demand for this procedure will be potentially explosive.
By Paul Kramer, MD
These devices will play an important role in CAS, but their use involves some trepidation.
By Takao Ohki, MD, PhD
What you need to know before performing your next CAS procedure.
By Frank J. Criado, MD
Are you aware of your responsibilities in complying with the rules and laws of the FDA?
By Dorothy B. Abel
It’s never too early (or too late) to prepare for life after medicine.
By Michael P. Hatch, CFP, JD
Steve Phurrough, MD, MPA, CMS Director of Coverage and Analaysis, explains the process by which new procedures, such as CAS, achieve CMS reimbursement.
By Craig McChesney, publisher, interviews Steve Phurrough, MD, MPA
A report on the early progress of two trials critical to our understanding of carotid artery stenting.
By Barry T. Katzen, MD; John R. Laird, Jr, MD; and Takao Ohki, MD, PhD
Knowing the risk factors for periprocedural complications can dramatically improve our CAS planning and outcomes.
By Robert S. Dieter, MD, and John R. Laird, Jr, MD
Abbott Perclose ProGlide
Dr. Simpson sheds light on some of the benefits of plaque excision, an innovative alternative to PTA and stenting.
By John B. Simpson, MD
One of the world’s foremost endovascular device experts discusses the reasons for the remarkable success of a relatively new technology and the promise it holds.